Pay to Marwadi

Company Profile

PHARMAIDS PHARMACEUTICALS LTD.

NSE : NABSE : 524572ISIN CODE : INE117D01018Industry : Pharmaceuticals & DrugsHouse : Private
BSE55.54-1.13 (-1.99 % )
PREV CLOSE (Rs.) 56.67
OPEN PRICE (Rs.) 55.54
BID PRICE (QTY) 55.55 (100 )
OFFER PRICE (QTY) 55.54 (18337 )
VOLUME 1075
TODAY'S LOW / HIGH (Rs.)55.54 55.54
52 WK LOW / HIGH (Rs.) 27.77 79.23
NSE
This Company is not listed in NSE

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.597055
Dividend Yield(%)
TTM EPS (Rs.)
P/E Ratio
Book Value (Rs.)
Face Value (Rs.)
MCap (Rs. in Mn)
Price/Earning (TTM)
Price/Sales (TTM)
Price/Book (MRQ)
PAT Margin (%) NA
ROCE (%) -63.94
Incorporation Year : 1989

Management Info :

Shankarappa Nagaraja Vinaya Babu - Chairman - Managing Director

Registered Office :

Address : Unit 201, 2nd Floor, Brigade Rubix,20/14, H M T Factory Main Road,Peenya Plantation,
Bengaluru,
Karnataka-560013

Phone : 080- 49784319

Website : www.pharmaids.com

Registrar's Details : Venture Capital & Corporate Investments Ltd
Aurum, Door No 4-50/P-II/57/4F&5F Plot No 57,4th & 5th Floors,Jayabheri Enclave Phase - II, Gachibowli,Hyderabad
Listing : BSE
NEWS More
26Mar03-26-2024$Pharmaids Pharmaceuticals informs about disclosure Pharmaids Pharmaceuticals in
In terms of Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015, Pharmaids Pharmaceuticals has informed about disclosure received from Shiromani Vijay (Immediate Relative of the Designated Person) in Form ‘B’ in respect to Purchase of Equity Shares of the Company pursuant to the Regulation 7(2)(a) of SEBI (Prohibition of Insider Trading) Regulations, 2015. 

The above information is a part of company’s filings submitted to BSE.
In terms of Regulation 7(2)(b) of SEBI (Prohibition of Insider..
06Mar03-06-2024$Pharmaids Pharmaceuticals informs about disclosure Pharmaids Pharmaceuticals in

Pharmaids Pharmaceuticals has informed that the exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Gokaram Ramkrishna Balaji.

The above information is a part of company’s filings submitted to BSE.

Pharmaids Pharmaceuticals has informed that the exchange has re..
05Mar03-05-2024$Allotment of Equity Shares Allotment of Equity Shares
Inter alia, approved the allotment of 1,28,56,578 fully paid-up equity shares having face value of Rs.10/-(Rupees Ten Only) each at a price of Rs.40.87/- (including premium of Rs.30.87/-) per equity shares to the allottees given below as an Annexure A, for the consideration other than cash (i.e., being a full consideration for acquisition of 36,73,308 equity shares of Rs.10/- (Rupees Ten Only) each of Adita Bio Sys Private Limited (?target company?), on preferential basis by way of private placement. These shares shall rank pari-passu, in all respects with the existing equity shares of the company. The company has received in-principle approval from the Stock Exchange i.e., BSE Limited for issue of the aforesaid Equity Shares on Preferential Basis on February 19, 2024. The Application for listing approval of the stock exchange for the equity shares allotted as above will be made in due course.
Inter alia, approved the allotment of 1,28,56,578 fully paid-up..
04Mar03-04-2024$H.G. Infra Engineering, Coal India and Avenue Supermarts to see some action today H.G. Infra Engineering, Coal

H.G. Infra Engineering has received the Letter of Acceptance (LoA) from South Central Railway for Doubling of Track between Karanjgaon station (Including) at Km 69.01(Ch 69010) & Aurangabad station (Including) at Km 113.15 (Ch 113150) [i.e. (44.14 km)] including Electrification and Signaling works in connection with Aurangabad-Ankai Doubling Project in Nanded Division of South-Central Railway. The project cost is Rs 447.11 crore and the construction period is 30 months.

Coal India has entered into Memorandum of Understanding (MoU) with Indian Institutes of Management (IIM) Mumbai and Sambalpur on March 1, 2024, marking a crucial step in multimodal connectivity infrastructure for coal transportation in alignment with the PM Gati Shakti National Master Plan 2021.

Avenue Supermarts has opened a new store at Hesaraghatta Road, Bengaluru (Karnataka). The total number of stores as on date stands at 347.

Lemon Tree Hotels has signed - Keys Lite by Lemon Tree Hotels, Urban Suites, Udaipur. The property, which will be franchised by Lemon Tree Hotels, is expected to open in FY25. Udaipur is often referred to as the Venice of the East on account of the seven turquoise lakes that dot the city. Bound by the verdant Aravalli hills, Udaipur holds a variety of attractions for its visitors including history, culture, scenic locations, opulent Rajput-era palaces and vibrant markets. 

Indian Railway Catering and Tourism Corporation (IRCTC) has signed Memorandum of Understanding (MoU) with CRPF on March 1, 2024 for On-board Catering services to allCAPF (CRPF, ITBP, BSF, CISF & SSB) personnel during movement for various law & order duties including Bye-elections.

Alfa Transformers has received a purchase order worth of Rs 27.39 crore from Gujarat Electricity Board. The company has bagged order for design, manufacturing and supply of 10 KVA 4,994 Nos of transformers from Vadodara plant. The said order is to be executed within 7 months from the date of receipt of order. 

Pharmaids Pharmaceuticals has completed the acquisition of 99.86% shareholding in Adita Bio Sys (Adita).  Adita is an unlisted private company, which is engaged in the GLP Developmental Services, Drug Discovery & Laboratory animals services & Animal Diet. The acquisition of the shares of Adita inter alia result in growth opportunities in line with strategic objectives of the Company. The acquisition of the target entity is within the main line of business of the listed entity. The cost of acquisition is Rs 52.54 crore. 

H.G. Infra Engineering has received the Letter of Acceptance (L..
02Mar03-02-2024$Pharmaids Pharmaceuticals acquires 99.86% shareholding in Adita Bio Sys Pharmaids Pharmaceuticals ac

Pharmaids Pharmaceuticals has completed the acquisition of 99.86% shareholding in Adita Bio Sys (Adita).  Adita is an unlisted private company, which is engaged in the GLP Developmental Services, Drug Discovery & Laboratory animals services & Animal Diet. The acquisition of the shares of Adita inter alia result in growth opportunities in line with strategic objectives of the Company. The acquisition of the target entity is within the main line of business of the listed entity. The cost of acquisition is Rs 52.54 crore. 

Pharmaids Pharmaceuticals is engaged in the business of trading and manufacturing of generics, bulk drugs and intermediaries etc.

Pharmaids Pharmaceuticals has completed the acquisition of 99.8..
Financials More
Rs. in Millions
QTR Dec 23 ANNUAL 23
Net Profit-16.34-75.57
Gross Profit -22.1 -99.09
Operating Profit -21.96-98.87
Net Sales 0.21
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Sanofi India (BSE)
 8525.00 (2.41%)
M.Cap ( in Cr)
19512.00
Dr. Reddy's Lab (BSE)
 6250.00 (0.72%)
M.Cap ( in Cr)
103954.47
Zydus Lifesciences (BSE)
 986.35 (3.43%)
M.Cap ( in Cr)
98444.90
Torrent Pharma (BSE)
 2663.60 (0.88%)
M.Cap ( in Cr)
90160.17
Sun Pharma Inds. (BSE)
 1524.50 (1.48%)
M.Cap ( in Cr)
365862.59
Shareholding Pattern More
NON-INSTITUTION 94.36 %
PROMOTERS 5.64 %
MUTUAL FUNDS/UTI 0 %
FI/BANKS/INSURANCE 0 %
GOVERNMENT 0 %
FII 0 %
MF HOLDINGS
Scheme NameHold(%)
No Data Found
F & O Quotes